James Investment Research’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.85M | Buy |
81,609
+4,382
| +6% | +$100K | 0.19% | 118 |
|
|
2026
Q1 | $1.8M | Buy |
77,227
+70
| +0.1% | +$1.51K | 0.2% | 110 |
|
|
2025
Q4 | $1.54M | Hold |
77,157
| – | – | 0.17% | 114 |
|
|
2025
Q3 | $1.41M | Buy |
77,157
+11,812
| +18% | +$230K | 0.15% | 131 |
|
|
2025
Q2 | $1.31M | Hold |
65,345
| – | – | 0.16% | 131 |
|
|
2025
Q1 | $1.18M | Hold |
65,345
| – | – | 0.15% | 135 |
|
|
2024
Q4 | $1.13M | Sell |
65,345
-3
| -0% | -$58 | 0.14% | 135 |
|
|
2024
Q3 | $1.26M | Hold |
65,348
| – | – | 0.15% | 135 |
|
|
2024
Q2 | $1.07M | Buy |
65,348
+8,536
| +15% | +$132K | 0.13% | 145 |
|
|
2024
Q1 | $866K | Sell |
56,812
-20,000
| -26% | -$314K | 0.1% | 163 |
|
|
2023
Q4 | $1.23M | Hold |
76,812
| – | – | 0.15% | 133 |
|
|
2023
Q3 | $998K | Hold |
76,812
| – | – | 0.13% | 138 |
|
|
2023
Q2 | $978K | Hold |
76,812
| – | – | 0.13% | 134 |
|
|
2023
Q1 | $864K | Sell |
76,812
-2,908
| -4% | -$35.3K | 0.11% | 140 |
|
|
2022
Q4 | $1.06M | Buy |
79,720
+12,478
| +19% | +$164K | 0.15% | 122 |
|
|
2022
Q3 | $781K | Sell |
67,242
-22,187
| -25% | -$304K | 0.11% | 144 |
|
|
2022
Q2 | $1.32M | Buy |
89,429
+8,896
| +11% | +$146K | 0.18% | 117 |
|
|
2022
Q1 | $1.56M | Buy |
80,533
+91
| +0.1% | +$1.63K | 0.16% | 127 |
|
|
2021
Q4 | $1.39M | Buy |
80,442
+10,000
| +14% | +$170K | 0.13% | 141 |
|
|
2021
Q3 | $1.18M | Hold |
70,442
| – | – | 0.11% | 142 |
|
|
2021
Q2 | $945K | Buy |
70,442
+9,310
| +15% | +$116K | 0.08% | 159 |
|
|
2021
Q1 | $731K | Sell |
61,132
-20,598
| -25% | -$249K | 0.07% | 170 |
|
|
2020
Q4 | $1.01M | Sell |
81,730
-21,561
| -21% | -$233K | 0.09% | 155 |
|
|
2020
Q3 | $1.08M | Sell |
103,291
-23,852
| -19% | -$303K | 0.1% | 154 |
|
|
2020
Q2 | $1.78M | Buy |
127,143
+8,953
| +8% | +$122K | 0.17% | 120 |
|
|
2020
Q1 | $1.39M | Sell |
118,190
-155,727
| -57% | -$2.06M | 0.14% | 122 |
|
|
2019
Q4 | $3.88M | Buy |
273,917
+183,248
| +202% | +$2.25M | 0.27% | 107 |
|
|
2019
Q3 | $955K | Sell |
90,669
-15,405
| -15% | -$184K | 0.07% | 187 |
|
|
2019
Q2 | $1.54M | Sell |
106,074
-15,335
| -13% | -$217K | 0.11% | 138 |
|
|
2019
Q1 | $1.7M | Sell |
121,409
-41,770
| -26% | -$676K | 0.11% | 145 |
|
|
2018
Q4 | $2.85M | Buy |
163,179
+93,659
| +135% | +$1.52M | 0.18% | 118 |
|
|
2018
Q3 | $1.06M | Sell |
69,520
-133,170
| -66% | -$1.92M | 0.04% | 468 |
|
|
2018
Q2 | $2.8M | Buy |
+202,690
| New | +$3.04M | 0.11% | 194 |
|
|
2017
Q4 | – | Sell |
-209,620
| Closed | -$2.96M | – | 806 |
|
|
2017
Q3 | $2.96M | Buy |
+209,620
| New | +$2.77M | 0.1% | 159 |
|
Other funds holding INVA
SFM
James Investment Research's INVA Position: Q2 2026 in Review
James Investment Research increased its Innoviva (INVA) stake by 5.7% in Q2 2026, buying an estimated $100K and bringing the position to 81,609 shares worth $1.85M. The position accounts for 0.19% of the portfolio, ranked #118.
James Investment Research first reported a position in INVA in Q3 2017 and has held it in 34 quarters since. The position peaked at $3.88M in Q4 2019. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.
- James Investment Research held 81,609 shares of Innoviva worth $1.85M as of Q2 2026.
- James Investment Research bought 4,382 Innoviva shares in Q2 2026, an estimated $100K.
- Innoviva made up 0.19% of James Investment Research's portfolio in Q2 2026, its #118 holding.
- James Investment Research first reported a position in Innoviva in Q3 2017 and has held it in 34 quarters since.
- James Investment Research's Innoviva position peaked at $3.88M in Q4 2019.
- 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.
Based on James Investment Research's 13F filing for Q2 2026, filed 24 Jul 2026.